(DIS)AGreement of Relatives Regarding Ethical End-of-life Decisions in ICU.
NCT ID: NCT05768906
Last Updated: 2025-09-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
429 participants
OBSERVATIONAL
2023-07-01
2025-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main objective of this study is to evaluate the frequency of disagreements between relatives and physicians over LST limitation decisions in adult intensive care.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Post-ICU Consultation : a Time to Discuss Advance Directives (CoPRADA)
NCT05817500
Withholding or Withdrawing of Life-sustaining Therapy in Great East French Region Intensive Care Units: a 1-month Survey
NCT05465187
Continuous Deep Sedation Until Death
NCT05108792
Study of the Preventable Passage of Patients Over 75 Years of Age to the Emergency Room of the CHRU of Nancy
NCT04464824
Advance Directives and End-of-life Decision Making in Intensive Care Medicine in Germany
NCT01294189
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Purpose The main objective of this study is to evaluate the frequency of disagreements between relatives and physicians over LST limitation decisions in adult intensive care.
The secondary objectives are:
* To assess the level of agreement/disagreement between family members and physicians regarding LST limitation decisions
* To assess the proportion of disagreements experienced as conflictual
* To assess the impact of the disagreement on the LST limitation decision (implementation of the decision, time between the decision and its implementation, length of hospitalization...)
* To describe possible factors that contribute to disagreement and conflict
* To describe national LST limitation decision-making practices.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Life-sustaining therapies limitation decision situations - observation only
For each participating center, consecutive inclusion of the first 10 life-sustaining therapies limitation decision situations from the study start date over a maximum of 12 months. Data collection for these patients especialy information concerning disagreements and even real legal conflicts on life-sustaining therapies limitation decisions between relatives and physicians.
observational
Observation of disagreements and even real legal conflicts on life-sustaining therapies limitation decisions between relatives and physicians
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
observational
Observation of disagreements and even real legal conflicts on life-sustaining therapies limitation decisions between relatives and physicians
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients hospitalized in a French intensive care unit
* Age of the patient ≥ 18 years
Exclusion Criteria
* Patient under guardianship
* Conscious patient, able to express himself/herself and able to decide jointly with the medical team
* Patient for whom a life-sustaining therapies limitation decision was already made prior to ICU admission.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Société Française d'Anesthésie et de Réanimation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mikhael Giabicani, MD
Role: STUDY_CHAIR
Hôpital Beaujon - 100 boulevard du Général Leclerc - 92110 Clichy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CH d'Aurillac (CH Henri Mondor)
Aurillac, , France
Hôpital Saint Camille
Bry-sur-Marne, , France
CHU de Clermont Ferrand - Hôpital Gabriel Montpied
Clermont-Ferrand, , France
Hôpital Beaujon - Réanimation chirurgicale polyvalente
Clichy, , France
Hôpital Beaujon - Réanimation hépato-digestive
Clichy, , France
CH de Dieppe
Dieppe, , France
CHU de Dijon
Dijon, , France
Hôpital Simone Veil- Eaubonne
Eaubonne, , France
CH de Grasse
Grasse, , France
GHEF (Grand Hôpital de l'Est Francilien)-Site de Marne la Vallée
Jossigny, , France
CHU de Grenoble-Alpes
La Tronche, , France
CH de Lens
Lens, , France
CHU de Montpellier - Gui de Chauliac
Montpellier, , France
Hôpital Lariboisière_APHP - Réanimation Chirurgicale Polyvalente
Paris, , France
Institut Mutualiste Montsouris -
Paris, , France
Fondation Ophtalmologique Adolphe de Rothschild
Paris, , France
Hôpital privé Claude Galien
Quincy-sous-Sénart, , France
CHU de Reims - Réanimation chirurgicale
Reims, , France
CHU de Toulouse-Rangueil - Réanimation Polyvalente
Toulouse, , France
CHBA Vannes-Auray
Vannes, , France
CH Versailles
Versailles, , France
HIA Robert Picqué
Villenave-d'Ornon, , France
Médipôle Lyon Villeurbanne
Villeurbanne, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
(DIS)AGREE - 2022-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.